Results A total of 1343 patients (13.2%) received aprotinin, 6776 patients (66.8%) received aminocaproic acid, and 2029 patients (20.0%) received no antifibrinolytic therapy.

• 结果：1343例患者（13.；2%25）应用了抑肽酶，6776例患者（66